Physician profile
Johnathon Recknagel
NPI 1942799804
$1,152.04
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $110 · 2023: $496 · 2024: $426 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $295.52 | 2023-2025 | |
| Evofem Biosciences, INC. | $130.32 | 2022-2024 | Phexxi |
| Hologic Sales and Service, LLC | $108.27 | 2023-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Abbvie INC. | $96.46 | 2022-2024 | |
| Exeltis, USA INC. | $94.03 | 2022-2023 | Slynd |
| Organon LLC | $81.11 | 2022-2024 | Nexplanon |
| Biogen, INC. | $76.90 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $50.94 | 2024 | |
| Sumitomo Pharma America, INC. | $41.77 | 2023-2024 | Myfembree, Gemtesa |
| Applied Medical Resources Corporation | $41.09 | 2023 | Gelpoint V-Path |
| Mayne Pharma Commercial LLC | $37.85 | 2023-2025 | |
| Astellas Pharma US INC | $28.68 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $18.87 | 2023 | Gardasil 9 |
| Coopersurgical, INC. | $17.35 | 2024 | Endosee |
| Aspira Women'S Health INC | $16.51 | 2023 | Ova1 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $16.37 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathon Recknagel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.